| CLINUVEL PHARMACEUTICALS |
| Australien |
| Gesundheit |
| AU000000CUV3 / A0JEGY |
| UR9 (Frankfurt) |
| FRA:UR9, ETR:UR9, UR9:GR |
| - |
| https://www.clinuvel.com |
|
Clinuvel Pharmaceuticals Ltd is a global specialty biotechnology company dedicated to the development and commercialization of innovative treatments for rare and severe medical conditions. The company..
>Volltext.. |
| 345.52 Mio. EUR |
| 220.66 Mio. EUR |
| 52.94 Mio. EUR |
| 23.65 Mio. EUR |
| 20.15 Mio. EUR |
| 0.4 EUR |
| 0.29 Mio. EUR |
| 15.61 Mio. EUR |
| 22.89 Mio. EUR |
| 8.24 |
| -3.35% |
| -8.95% |
| 0.03 EUR |
| 0.44% |
| 0.44% |
| 04.09.25 - 0.027875€ 05.09.24 - 0.027875€ >weitere anzeigen... |
| - |
| CLINUVEL |
| 27.02.26 |
|
||||
|
||||
|
||||
|
||||
|